Leah Moursalin
Dr. Leah Moursalin is the Head of Clinical Research at the Alzheimer's Research Centre in the UK. She recently gained attention for her insights on the potential neuroprotective effects of GLP-1 receptor agonists, such as semaglutide, in reducing the risk of dementia, as highlighted in recent studies. Moursalin emphasized the need for further research to fully understand the relationship between these medications and cognitive health, while also considering broader factors affecting overall well-being.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Saudi Arabia | 1 | 7.00 | 0.07% | +0% | 34,813,871 | 26,078 | $700,000 | 524$ |
| Totals | 1 | 34,813,871 | 26,078 | $700,000 | 524$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Saudi Arabia:
Dr. Leah Moursalin, head of clinical research at the Alzheimer's Research Center in the UK, stated that the increasing evidence is hopeful.
7